LDHA and neoplasm: NADH‐competitive LDHA inhibitors, including Gossypol (also known as AT‐101), FX11 (3,3'‐dihydroxy‐6‐methyl‐7‐(phenylmethyl)‐4‐propyl‐naphthalene‐1‐carboxylic acid), and Quinolinesulfonamide, have also been demonstrated to inhibit tumor cell proliferation.